Page last updated: 2024-11-06

prednisolone and Chronic Insomnia

prednisolone has been researched along with Chronic Insomnia in 3 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Sweet's syndrome is an uncommon acute skin disease, associated with a variety of medical problems."1.33Bortezomib-induced Sweet's syndrome. ( De Raeve, H; Lambert, J; Rombouts, S; Schroyens, W; Van de Velde, A; Van de Voorde, K; Van Regenmortel, N, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakajima, A1
Doki, K1
Homma, M1
Sagae, T1
Saito, R1
Ito, S1
Sumida, T1
Kohda, Y1
MAGUIRE, A1
Van Regenmortel, N1
Van de Voorde, K1
De Raeve, H1
Rombouts, S1
Van de Velde, A1
Lambert, J1
Schroyens, W1

Other Studies

3 other studies available for prednisolone and Chronic Insomnia

ArticleYear
[Investigation of glucocorticoid-induced side effects in patients with autoimmune diseases].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2009, Volume: 129, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Appetite; Autoimmune Diseases; Candidiasis, Oral; Dose-Response Rela

2009
A TRIAL OF AMOPYROQUIN IN THE TREATMENT OF CHRONIC DISCOID LUPUS ERYTHEMATOSUS.
    The British journal of dermatology, 1964, Volume: 76

    Topics: Aminoquinolines; Antimalarials; Aspartate Aminotransferases; Biomedical Research; Leukopenia; Lupus

1964
Bortezomib-induced Sweet's syndrome.
    Haematologica, 2005, Volume: 90, Issue:12 Suppl

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Drug Administration

2005